Alzheimer s Disease- the spectrum of clinical presentations

Similar documents
CRITERIA FOR AD DEMENTIA June 11, 2010

2016 Programs & Information

Primary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment

F rontotemporal dementia (FTD) is the most common

Primary Endpoints in Alzheimer s Dementia

Dementia: Delivering the Diagnosis

Is there a Distinct Phenotype to Memory Loss in Alzheimer's Disease?

In conjunction with clinical history, structural

1 st December Cardiff Crown Court. Dear. Claimant: Maurice Kirk Date of Birth: 12 th March 1945

Montreal Cognitive Assessment (MoCA) Debbie Froese, B.M.R.-O.T., B.A. Christine Knight, Ph.D.,R.Psych.

Communication Strategies for Primary Progressive Aphasia & FTD s:

The Role of Neuropsychological Testing in Guiding Decision- Making Related to Dementia

1695 N.W. 9th Avenue, Suite 3302H Miami, FL Days and Hours: Monday Friday 8:30a.m. 6:00p.m. (305) (JMH, Downtown)

Life Interests and Values (LIV) cards

Social Security Disability Insurance and young onset dementia: A guide for employers and employees

FUNCTIONAL EEG ANALYZE IN AUTISM. Dr. Plamen Dimitrov

Magnetic Resonance Techniques in Neurodegenerative Diseases First Course Alzheimer s disease and frontotemporal lobar degeneration spectrum

Lewy body dementia Referral for a Diagnosis

Biomarkers for Alzheimer's Disease in Down Syndrome

Bedside cognitive examination beyond the MMSE. Dr Richard Perry Dept of Neurosciences Imperial College

How To Treat Aphasia

What is PD? Dr Catherine Dotchin MD MRCP Consultant Geriatrician

Simposio Internacional: International Symposium Murray Grossman

Dementia & Movement Disorders

Johns Hopkins Memory & Alzheimer s Treatment Center

Guidance for Industry Alzheimer s Disease: Developing Drugs for the Treatment of Early Stage Disease

Cholinesterase inhibitors and memantine use for Alzheimer s disease TOPIC REVIEW

2014 Alzheimer s Disease Facts and Figures

Overview. Neuropsychological Assessment in Stroke. Why a Neuropsychologist. How to make a referral. Referral Questions 11/6/2013

Dementia Causes and Neuropsychological Evaluation of the Older Adult

Alzheimer s disease. What is Alzheimer s disease?

Steps to getting a diagnosis: Finding out if it s Alzheimer s Disease.

2012 Medical School for Actuaries Nov. 6-7, 2012 Session #1: Alzheimer s Disease

Collaborative Care for Alzheimer s Disease

Alzheimer s disease. The importance of early diagnosis

Continence in Dementia. Elizabeth Rand Manager, Cognitive Dementia & Memory Service (CDAMS) Caulfield Hospital

Introduction to Neuropsychological Assessment

THEORIES OF NEUROLOGICAL AGING AND DEMENTIA

ANXIETY & COGNITIVE IMPAIRMENT

Sandro Sorbi DIPARTIMENTO DI SCIENZE NEUROLOGICHE E PSICHIATRICHE

PSYCHOLOGICAL AND NEUROPSYCHOLOGICAL TESTING

Attention, memory and learning and acquired brain injury. Vicki Anderson. Jamie M. Attention & learning: an information processing model

Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) (APA, 2001) 10

Response from Neurobehaviour Clinic at National Rehabilitation Hospital to Submission to Second Independent Monitoring Group: A Vision for Change

CLINICAL OUTCOME SCORES FOR THE FAMILY HOPE CENTER FOR 13.0 YEARS, COMPARED TO NATIONAL SAMPLE OF OUTPATIENT REHABILITATION FOR SIMILAR DIAGNOSES

Auditory memory and cerebral reorganization in post-linguistically deaf adults

Diagnosis and Initial Management of Cognitive Disorders

doi: /brain/awr179 Brain 2011: 134;

Frequently Asked Questions

1: Motor neurone disease (MND)

Neuropsychological Testing

Cognitive Assessment and Mini Mental Status Exam for Nurses. Sarah Krieger-Frost RN MN/ Heather Rea MSW RSW Seniors Mental Health Capital District

Neuropsychology Residency Training Manual. Departments of Psychiatry and Neurology. Indiana University School of Medicine

Objectives. Aging and Forgetfulness Define Dementia Types of Dementia Treatment

Evaluation of Cognitive Status and Dementia in OCTO Twin

The diagnosis of dementia due to Alzheimer s disease: Recommendations from the National Institute on Aging and the Alzheimer s Association workgroup

Psychological and Neuropsychological Testing

F rontotemporal dementia is the term currently favoured to

Frontotemporal Dementia: Clinicopathological Correlations

Memory Rehabilitation in Early Dementia. Diana Golvers Clinical Psychologist Central Dementia Service

Update on Treatment of the Dementias

Chemobrain. Halle C.F. Moore, MD The Cleveland Clinic October 3, 2015

Age Associated Cognitive Decline and Mild Cognitive Impairment (MCI)

Geriatric Psychiatrists

Retinal Imaging Biomarkers for Early Diagnosis of Alzheimer s Disease

Normal and Abnormal Aging and the Brain. Joel Kramer, PsyD Saul Villeda, PhD Kristine Yaffe, MD

The John Hopkins Behavioral Neurology and Neuropsychiatry Fellowship Program Mission Statement:

What is vascular dementia?

Neuropsychology testing the brain

Meeting the Needs of Aging Persons. Aging in Individuals with a

Changing the Trajectory of Alzheimer s Disease: How a Treatment by 2025 Saves Lives and Dollars

UPDATES TO NEUROCOGNITIVE DISORDERS IN DSM-5 and DSM-5 DESK REFERENCE UPDATED

Montreal Cognitive Assessment (MoCA) as Screening tool for cognitive impairment in mtbi.

2 Neurons. 4 The Brain: Cortex

J/601/2874. This unit must be assessed in accordance with Skills for Care and Development s QCF Assessment Principles.

PSYC PSYCHOLOGY Calendar Proof

Overview of DSM-5. With a Focus on Adult Disorders. Gordon Clark, MD

TESTING GUIDELINES PerformCare: HealthChoices. Guidelines for Psychological Testing

Frontotemporal dementia (FTD)

Patients with dementia and other types of structural brain injury are predisposed to delirium (i.e., abrupt onset, temporary confusion caused by

Neuropsychology of Frontotemporal Dementia and Primary Progressive Aphasia. Beth Borosh, Nancy Johnson ABSTRACT

SPECIFIC LEARNING DISABILITIES (SLD)

IBADAN STUDY OF AGEING (ISA): RATIONALE AND METHODS. Oye Gureje Professor of Psychiatry University of Ibadan Nigeria

ADVISORY REPORT OF THE SUPERIOR HEALTH COUNCIL no. 8890

Intellectual Symptoms Amnesia: Loss of memory function

Changes affecting concentration,

How To Find Out If The Gulf War And Health Effects Of Serving In The Gulf Wars Are Linked To Health Outcomes

Connectivity theory of Autism: Using connectivity measures in the assessment and treatment of autistic disorders

WMS III to WMS IV: Rationale for Change

Mental health issues in the elderly. January 28th 2008 Presented by Éric R. Thériault

Required Documentation of Disability for Accommodation of USCBP Pre-Employment Testing and Supervisory/Managerial Assessments 1 (July 25, 2005 )

Transcription:

Alzheimer s Disease- the spectrum of clinical presentations Associate Professor Michael Woodward Chief Medical Advisor Alzheimer s Australia Vic Alzheimer s Australia National Conference 2013 Hobart

How do we characterize Alzheimer s disease? Age of onset Family history/genetics Initial clinical features Subsequent clinical features Pathology Neuroimaging/other biomarkers

Alzheimer s ain t Alzheimer s Spectrum of initial presentations and subsequent course Likely correlates with distribution and progression of pathology and development/presence of any additional pathology Reflected in neuroimaging Autopsy only shows us the final picture by then, most pathological patterns have merged

THE BINDING OF PIB MATCHES THE HISTOPATHOLOGY OF Aβ. Braak Stages (1997) A B C

Clinical presentations ( phenotypes ) of AD Amnestic Most common Language Logopenic aphasia Visuospatial Posterior cortical atrophy Behavioural Frontal variant AD

Amnestic AD Memory loss a prominent early feature esp episodic memory not greatly assisted by cueing Early pathology in the limbic system, including hippocampus Over time, pathology spreads, as in the Braak stagings and clinical features expand to include visuospatial, language and behavioural features more advanced stages involve executive function and eventually motor function But much variation in progression and timing of subsequent clinical features

Hippocampal atrophy in amnestic AD

Logopenic Aphasia 1 Prominent early language changes Slow speech rate Long word-finding pauses Repetition and comprehension impaired for sentences but preserved for single words Naming moderately affected Left superior and middle temporal gyri and inferior parietal lobules affected 1. Gorno-Tempini Neurology 2008;71:1227-34

Logopenic apahasia-mri and SPECT

Logopenic Aphasia: FDG-PET

Posterior Cortical Atrophy Early difficulties with visual and spatial functions recognizing faces working out what an object is working out how to dress/undress locating chair position when sitting Later, can develop difficulties with literacy and numeracy Memory and language preserved early on Often affects younger people (50s and 60s) Prominent atrophy of the posterior cortical regions

Posterior Cortical Atrophy

Posterior Cortical Atrophy 3.0 1.5 0.0

Frontal variant AD Older patient Behavioural/frontal features prominent early Amnestic disorder usually also present Clinical features suggest AD but differential diagnosis is FrontoTemporal Lobar Degeneration Neuroimaging often consistent with AD

Pathology in FvAD/FTLD Johnson: predominant frontal NFTs in AD with behavioural onset 1 Woodward: 37 of 45 autopsied cases from ACCORD dementia cohort had AD pathology 2 8 had coexisting FTLD-TDP43 pathology but only one had clinical diagnosis of AD + FTLD In a pathological series of 60 patients with clinically diagnosed FTLD, 7% had AD pathology alone and a further 10% had mixed AD and glial pathology 3 1. Johnson JK, Head E, Kim R, Stark A, Arnold MD, Cotman CW. Clinical and pathological evidence for a frontal variant of Alzheimer s disease. Neurology 1999: 56: 1233-9 2. Woodward M, Mackenzie I, Hsiung G-Y R, Jacova C, Feldman H. High prevalence of multiple pathologies in dementia. European Geriatric Medicine 2010; 1: 259-65 3. Kertesz A, McMonagle P, Blair M, Davidson W, Munoz DG. The evolution and pathology of frontotemporal dementia. Brain 2005; 128: 1996-2005

Distinguishing AD with frontal features from FTLD Can be difficult if relying on diagnostic criteria NINCDS-ADRDA criteria show low specificity in distinguishing AD from FTLD most FTLD patients fulfil criteria for AD 1 Lund- Manchester criteria for FT(L)D frequently misdiagnose AD 34% of 185 community dementia cases with AD fulfilled these criteria for FTLD 2 FDG-PET scanning in a series of autopsy proven FTLD and AD cases demonstrated much overlap in patterns of hypometabolism 3 AD cases were not evaluated for frontal clinical features 1. Varma AR, Snowden JS, Lloyd JJ, Talbot PR, Mann DMA, Neary D. 1999. Evaluation of the NINCDS-ADRDA Criteria in the differentiation of Alzheimer s disease and frontotemporal dementia. J Neurol Neurosurg Psychiatry 66: 184-8 2. Ikeda M, Ishikawa T, Tanabe, H. 2004. Epidemiology of frontotemporal lobar degeneration. Dement Geriatr Cogn Disord 17: 265-8. 3. Womack KB, Diaz-Arrastia R, Aizenstein HJ, et al. Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors. Arch Neurol 68: 2011; 329-37

FTLD- also not a single clinical entity Rapid evolution in our understanding of FTLD Can be cut pathologically, clinically, genetically and other ways correlation not always strong Clinically, 3 main clusters: 1. Frontal/behavioural onset (sometimes called FvFTLD or BvFTLD) 2. Language onset 3. Motor onset/ features

Using assessment scales to distinguish AD, FvAD and FTLD Several scales suitable for assessing frontal function Frontal Assessment Battery (FAB) Assesses executive dysfunction Exit- 25 Executive, cognitive Frontal Behavioural Inventory (FBI) Behavioural Neuropsychiatric Inventory (NPI) Psychiatric features

Defining FvAD- ACCORD Cohort 1 670 cases with dementia 71 of the AD cases (without additional clinical diagnosis of FTLD) had the FBI 36 FTLD cases- 26 had the FBI administered Baseline data utilised FBI scores for AD cases arrayed and most frontal quartile defined as FvAD. 1. Woodward M, Jacova C, Black SE, Kertesz A, Mackenzie IR, Feldman H, the ACCORD Investigators. Differentiating the frontal variant of Alzheimer s disease. Int J Geriatr Psychiatry 2010; 25: 732-8

Continued in Part 2